BlackRock’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-58,603
| Closed | -$462K | – | 6111 |
|
|
2022
Q1 | $462K | Buy |
58,603
+38
| +0.1% | +$418 | ﹤0.01% | 4895 |
|
|
2021
Q4 | $963K | Buy |
58,565
+291
| +0.5% | +$6.14K | ﹤0.01% | 4680 |
|
|
2021
Q3 | $1.47M | Buy |
58,274
+91
| +0.2% | +$2.36K | ﹤0.01% | 4437 |
|
|
2021
Q2 | $1.93M | Sell |
58,183
-10,964
| -16% | -$353K | ﹤0.01% | 4283 |
|
|
2021
Q1 | $3M | Buy |
69,147
+37,543
| +119% | +$1.57M | ﹤0.01% | 4157 |
|
|
2020
Q4 | $583K | Hold |
31,604
| – | – | ﹤0.01% | 4324 |
|
|
2020
Q3 | $1.79M | Buy |
31,604
+15,143
| +92% | +$705K | ﹤0.01% | 3934 |
|
|
2020
Q2 | $493K | Buy |
16,461
+5,442
| +49% | +$154K | ﹤0.01% | 4212 |
|
|
2020
Q1 | $216K | Buy |
11,019
+698
| +7% | +$23.4K | ﹤0.01% | 4218 |
|
|
2019
Q4 | $549K | Sell |
10,321
-161
| -2% | -$9.93K | ﹤0.01% | 4141 |
|
|
2019
Q3 | $572K | Hold |
10,482
| – | – | ﹤0.01% | 4132 |
|
|
2019
Q2 | $1.2M | Buy |
10,482
+1,574
| +18% | +$186K | ﹤0.01% | 3956 |
|
|
2019
Q1 | $1.49M | Buy |
8,908
+8,121
| +1,032% | +$995K | ﹤0.01% | 3800 |
|
|
2018
Q4 | $58K | Hold |
787
| – | – | ﹤0.01% | 4457 |
|
|
2018
Q3 | $113K | Hold |
787
| – | – | ﹤0.01% | 4438 |
|
|
2018
Q2 | $113K | Buy |
787
+652
| +483% | +$98.1K | ﹤0.01% | 4445 |
|
|
2018
Q1 | $24K | Sell |
135
-3
| -2% | -$1K | ﹤0.01% | 4547 |
|
|
2017
Q4 | $51K | Buy |
138
+6
| +5% | +$3.01K | ﹤0.01% | 4434 |
|
|
2017
Q3 | $77K | Sell |
132
-7
| -5% | -$5.13K | ﹤0.01% | 4408 |
|
|
2017
Q2 | $137K | Buy |
139
+135
| +3,375% | +$139K | ﹤0.01% | 4342 |
|
|
2017
Q1 | $6K | Buy |
+4
| New | +$4.83K | ﹤0.01% | 4781 |
|
Other funds holding ZSAN
BlackRock's ZSAN Position: Q2 2022 in Review
BlackRock sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 58,603 shares — an estimated $462K sold.
BlackRock first reported a position in ZSAN in Q1 2017 and held it in 21 quarters. The position peaked at $3M in Q1 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.
- BlackRock reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
- BlackRock sold 58,603 Zosano Pharma Corporation shares in Q2 2022, an estimated $462K.
- BlackRock first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 21 quarters.
- BlackRock's Zosano Pharma Corporation position peaked at $3M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.